These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 14703419

  • 1. [Peroxisome proliferation-activated receptor-gamma ligands ameliorate autoimmune myocarditis associated with inhibition of T cell immunity].
    Yuan ZY, Liu Y, Liu Y, Zhang JJ, Kishimoto C, Liu ZQ.
    Zhonghua Yi Xue Za Zhi; 2003 Dec 10; 83(23):2067-72. PubMed ID: 14703419
    [Abstract] [Full Text] [Related]

  • 2. Peroxisome proliferation-activated receptor-gamma ligands ameliorate experimental autoimmune myocarditis.
    Yuan Z, Liu Y, Liu Y, Zhang J, Kishimoto C, Wang Y, Ma A, Liu Z.
    Cardiovasc Res; 2003 Sep 01; 59(3):685-94. PubMed ID: 14499870
    [Abstract] [Full Text] [Related]

  • 3. Peroxisome proliferator-activated receptor-gamma ligands ameliorate experimental autoimmune myocarditis associated with inhibition of self-sensitive T cells.
    Yuan Z, Liu Y, Liu Y, Zhang J, Kishimoto C, Ma A, Liu Z.
    J Cardiovasc Pharmacol; 2004 Jun 01; 43(6):868-75. PubMed ID: 15167281
    [Abstract] [Full Text] [Related]

  • 4. Cardioprotective effects of peroxisome proliferator activated receptor gamma activators on acute myocarditis: anti-inflammatory actions associated with nuclear factor kappaB blockade.
    Yuan Z, Liu Y, Liu Y, Zhang J, Kishimoto C, Wang Y, Ma A, Liu Z.
    Heart; 2005 Sep 01; 91(9):1203-8. PubMed ID: 15774612
    [Abstract] [Full Text] [Related]

  • 5. [Apoptosis of human lung cancer cells induced by activated peroxisome proliferator-activated receptor-gamma and its mechanism].
    Zhang M, Zou P, Bai M, Tao XN, Jin Y, Guo R.
    Zhonghua Yi Xue Za Zhi; 2003 Jul 10; 83(13):1169-72. PubMed ID: 12921638
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Peroxisome proliferator-activated receptor-gamma agonist 15-deoxy-Delta(12,14)-prostaglandin J(2) ameliorates experimental autoimmune encephalomyelitis.
    Diab A, Deng C, Smith JD, Hussain RZ, Phanavanh B, Lovett-Racke AE, Drew PD, Racke MK.
    J Immunol; 2002 Mar 01; 168(5):2508-15. PubMed ID: 11859145
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. 15-deoxy-delta(12,14)-PGJ(2) induces synoviocyte apoptosis and suppresses adjuvant-induced arthritis in rats.
    Kawahito Y, Kondo M, Tsubouchi Y, Hashiramoto A, Bishop-Bailey D, Inoue K, Kohno M, Yamada R, Hla T, Sano H.
    J Clin Invest; 2000 Jul 01; 106(2):189-97. PubMed ID: 10903334
    [Abstract] [Full Text] [Related]

  • 11. Pioglitazone, a peroxisome proliferator-activated receptor gamma activator, ameliorates experimental autoimmune myocarditis by modulating Th1/Th2 balance.
    Hasegawa H, Takano H, Zou Y, Qin Y, Hizukuri K, Odaka K, Toyozaki T, Komuro I.
    J Mol Cell Cardiol; 2005 Feb 01; 38(2):257-65. PubMed ID: 15698832
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Peroxisome proliferator-activated receptor-gamma ligands inhibit TGF-beta 1-induced fibronectin expression in glomerular mesangial cells.
    Guo B, Koya D, Isono M, Sugimoto T, Kashiwagi A, Haneda M.
    Diabetes; 2004 Jan 01; 53(1):200-8. PubMed ID: 14693716
    [Abstract] [Full Text] [Related]

  • 15. Ligands of the peroxisome proliferator-activated receptors (PPAR-gamma and PPAR-alpha) reduce myocardial infarct size.
    Wayman NS, Hattori Y, McDonald MC, Mota-Filipe H, Cuzzocrea S, Pisano B, Chatterjee PK, Thiemermann C.
    FASEB J; 2002 Jul 01; 16(9):1027-40. PubMed ID: 12087064
    [Abstract] [Full Text] [Related]

  • 16. Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.
    Cuzzocrea S, Pisano B, Dugo L, Ianaro A, Patel NS, Di Paola R, Genovese T, Chatterjee PK, Di Rosa M, Caputi AP, Thiemermann C.
    Br J Pharmacol; 2003 Sep 01; 140(2):366-76. PubMed ID: 12970094
    [Abstract] [Full Text] [Related]

  • 17. Differential effects of peroxisome proliferator activated receptor-gamma (PPAR gamma) ligands in proximal tubular cells: thiazolidinediones are partial PPAR gamma agonists.
    Chana RS, Lewington AJ, Brunskill NJ.
    Kidney Int; 2004 Jun 01; 65(6):2081-90. PubMed ID: 15149321
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of interleukin-4 production in CD4+ T cells by peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligands: involvement of physical association between PPAR-gamma and the nuclear factor of activated T cells transcription factor.
    Chung SW, Kang BY, Kim TS.
    Mol Pharmacol; 2003 Nov 01; 64(5):1169-79. PubMed ID: 14573767
    [Abstract] [Full Text] [Related]

  • 19. Human B lymphocytes and B lymphomas express PPAR-gamma and are killed by PPAR-gamma agonists.
    Padilla J, Leung E, Phipps RP.
    Clin Immunol; 2002 Apr 01; 103(1):22-33. PubMed ID: 11987982
    [Abstract] [Full Text] [Related]

  • 20. The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses.
    Clark RB, Bishop-Bailey D, Estrada-Hernandez T, Hla T, Puddington L, Padula SJ.
    J Immunol; 2000 Feb 01; 164(3):1364-71. PubMed ID: 10640751
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.